#Malaria3

14 Nov 2025

New malaria drug GanLum shows strong trial results

Novartis announced GanLum, a malaria treatment with a new molecule, ganaplacide. In a late-stage trial of over 1,600 patients in 12 sub-Saharan African countries, GanLum cured 97.4% and may be available in 2027.

A1 A2 B1 B2 Read

Photo by Mufid Majnun, Unsplash

14 Nov 2025

Study finds Abbott-Bioline malaria test gives many false negatives

A study on the Thailand–Myanmar border found the Abbott-Bioline rapid malaria test missed many infections. Researchers call it “not fit for purpose”; WHO and the manufacturer are reviewing the test and further studies are under way.

Level

A1 A2 B1 B2 Read

27 Aug 2025

Coartem Baby: first malaria medicine for newborns

Swissmedic approved Coartem Baby in July 2025, the first antimalarial made for newborns under five kilograms. The tablet aims to close a long treatment gap in malaria-endemic parts of Sub-Saharan Africa.

Level

A1 A2 B1 B2 Read

No more articles